Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg

Clinical trial NCT00019968 · COMPLETED

Trial details

NCT number: NCT00019968
Sponsor: National Institutes of Health Clinical Center (CC)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Stage IVB Adult Soft Tissue Sarcoma Stage IIB Adult Soft Tissue Sarcoma Stage IIC Adult Soft Tissue Sarcoma Recurrent Adult Soft Tissue Sarcoma Stage IVA Adult Soft Tissue Sarcoma Stage III Adult Soft Tissue Sarcoma

Start date: 1999-08-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.